Integrated Stock Price, News & Analysis

Integrated Ventures Inc. (OTCQB: INTV) has announced the launch of MedWell Facilities, , a new subsidiary focused on facilities management in the health and wellness industry. MedWell Facilities has signed a lease agreement with Giant Fitness Clubs to develop wellness clinics inside their gyms, starting with their flagship location that attracts over 2,000 daily visitors.

The strategic partnership aims to create comprehensive health and wellness environments in prime locations, offering services such as weight management, IV therapy, peptide treatments, and vitamin injections. The first clinic is expected to be operational by November 15, 2024. This initiative is part of Integrated Ventures' strategy to diversify revenue streams through base rents and management fees via its Facilities Management MSO model.

Integrated Ventures Inc (OTCQB: INTV) has filed its Form 10K/Annual Report for the financial period ending July 30, 2024. The company reported total annual revenues of $5,863,935 for 2024, compared to $3,862,849 in 2023. Total liquid capital increased to $1,771,891 in 2024 from $705,423 in 2023. However, total assets decreased to $3,942,691 in 2024 from $6,590,569 in 2023, mainly due to impairment of property and mining equipment.

The company reported a net loss of $11,524,357 in 2024, an improvement from the $25,459,967 loss in 2023. Integrated Ventures has expanded its operations into the health and wellness sector, focusing on weight loss management solutions. The company has launched four wholly owned subsidiaries: digital currency mining and hosting, MedWell USA, MedWell Direct, and MedWell Facilities.

Integrated Ventures Inc. (OTCQB: INTV) has announced a strategic partnership through its subsidiary, MedWell USA, . The company has signed a Management Services Organization (MSO) agreement with an FDA-licensed pharmaceutical manufacturer, enabling MedWell USA to act as a Procurement Agent for Semaglutide, a leading weight management drug.

MedWell USA will target health providers, wellness clinics, and gyms across 23 states, expanding its presence in the health and wellness industry. The global market for Semaglutide is projected to reach $10.6 billion by 2028, with a CAGR of 14.5%.

The company plans to expand its offerings to include a broader range of pharmaceuticals and medical supplies, with potential for another MSO agreement for Tirzepatide, another GLP-1 based drug. Integrated Ventures Inc. aims to become a trusted partner in the healthcare and wellness industry through its subsidiary's B2B procurement services.

The global telehealth market is projected to reach $539.73 billion by 2029, with a CAGR of 21.6%. The US telehealth market is expected to hit $35.58 billion by 2030. Integrated Ventures, Inc. (OTCQB: INTV) has launched MedWellDirect, , a telemedicine provider focusing on weight loss and GLP-1 products. INTV also acquired a 51% stake in GetTrim.Com™, positioning itself in the growing medical weight loss industry.

Other companies in the sector are showing strong growth. Hims & Hers Health Inc. reported a 43% year-over-year increase in subscribers, approaching 1.9 million. LifeMD, Inc. saw a 67% increase in telehealth revenue over the prior year. Lemonaid Health, Inc. is now offering Ozempic®, Wegovy®, and compounded semaglutide through a subscription-based weight loss program.

The market for telehealth weight loss services was estimated at $6.9 billion in 2023, with projected annual growth of 7.5% to 2028.

Integrated Ventures Inc. (OTCQB: INTV) has announced two significant developments: (1) the formation of MedWellDirect, , a fully-owned subsidiary focused on Direct-To-Consumer telemedicine solutions for weight loss and GLP-1 products, and (2) the acquisition of a 51% stake in GetTrim.Com, owned by Healthy Lifestyle USA.

This strategic move positions INTV at the forefront of the rapidly expanding medical weight loss industry, driven by increasing consumer adoption of medications like Semaglutide and Tirzepatide. GetTrim.Com and JoinTrim.Com offer unique weight loss solutions supported by advanced telemedicine capabilities and sophisticated marketing funnels. The platforms are compliant with HIPAA and GDPR regulations and can operate in 49 states, including major markets like California, Florida, Texas, and New York.

Investorideas.com reports on the expanding global GLP-1 receptor agonist market, highlighting Integrated Ventures, Inc. (OTCQB: INTV) as a new player. The market is growing at a CAGR of 21.65% from 2024 to 2030, driven by strong product pipelines and formulation advancements. INTV announced its entry into the health and wellness sector through its subsidiary MedWell USA, , focusing on B2B procurement for pharmaceutical products, particularly in medical weight loss and GLP-1 markets.

The GLP-1 market for obesity and diabetes is forecasted to reach $129 billion by 2029, with 40 million users and a 30% CAGR. Other companies like Hims & Hers Health and Viking Therapeutics are also making strides in the GLP-1 and weight loss markets. The sector's future looks promising, with companies expanding geographically and seeking approvals for additional indications like obesity and cardiovascular events.

Integrated Ventures (OTCQB: INTV) has announced its strategic entry into the health and wellness sector, focusing on the GLP-1 market. The company has established a new subsidiary, MedWell USA, , which will serve as a B2B Procurement Agent for pharmaceutical products, particularly in the medical weight loss market.

MedWell USA will target B2B clients such as medical offices, fitness facilities, and wellness clinics. CEO Steve Rubakh highlighted the significant growth potential in this sector, citing a UBS Securities forecast that projects the combined GLP-1 market for obesity and diabetes to reach $129 billion by 2029, with 40 million users and a 30% CAGR.

Integrated Ventures plans to establish two more subsidiaries and is finalizing strategic joint ventures to penetrate the health and wellness market effectively.

Integrated Ventures (OTCQB: INTV) reported record profits and revenues for Q3 2024, ending March 31, 2024. The company achieved mining revenues of $1,983,250, up from $1,472,813 in Q3 2023, and a net income of $297,283, reversing a previous loss of $1,766,615. Liquid assets reached $2,007,296, the highest ever, and will support potential acquisitions and new mining equipment. The CEO highlighted the adoption of fair value accounting standards for crypto assets. The report also noted a significant drop in Bitcoin mining difficulty, potentially increasing future profits for miners.

Integrated Ventures (OTCQB: INTV) has announced its Q3/2024 financial results, highlighting a record quarterly mining revenue of $1,983,250 and positive earnings of 0.05 cents per share. This reflects a significant improvement from Q3/2023, which saw a loss of $1,766,615. CEO Steve Rubakh emphasized the company's strong liquidity position, aimed at supporting potential M&A transactions and acquiring more efficient mining equipment. The company reported total assets of $5,947,859 and total liquid assets of $2,007,296. A new accounting standard (ASU-2023-08) was adopted for booking crypto assets using the fair value method.